U.S. Arthroscopy Devices Market Size Worth to be US$ 2.5 billion in 2017 and Expected to Grow in Double Digit Figures with a CAGR of 6.1% by 2023

Optima Insights offers a latest report on “Arthroscopy Devices Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report presents current market analysis, upcoming as well as future opportunities, revenue growth, pricing and profitability. The report contains basic, secondary and advanced information pertaining to the Arthroscopy Devices Market status and trend, size, share, growth, trends, segment and forecasts

According to Optima Insights, the U.S. Arthroscopy Devices Market is estimated to be valued at US$ 2.5 billion in 2017 and is projected to exhibit a CAGR of 6.1% over the forecast period (2019 – 2023).

For Any Queries, Make an Inquiry Here @ https://www.optimainsights.org/categories/orthopedic-spine-trauma-devices

Key Trends and Analysis of the U.S. Arthroscopy Devices Market:

Arthroscopy is a minimally invasive surgical procedure which is operated with the use of arthroscopes, defined as a device used to visualize the joints during arthroscopic surgery. The device is integrated with a tiny lens and fiber optic light connected to a camera and monitor which allows the orthopedic surgeon to observe the surgery site and perform variety of procedures, accordingly.

The arthroscopic techniques are applied majorly on shoulder and knee surgeries. Increase in geriatric population suffers from trauma and fall injuries, innovative product launches in the arthroscopic sectorand technologically upgraded devices such as true 1080p HD cameras, LED lighting, and image management with an intuitive tablet controller are the key drivers for U.S arthroscopy devices market.The arthroscopic process possesses various benefits as reduced recovery time, minimal incision, shorter hospital stays, and less complications post-surgery.

Other restraining factors are lack of skilled professionals, increase in cost of arthroscopic devices hinder the market growth over the forecast period.

Arthrex is the leader in 4K technology and continues to push technology with the introduction of 4K 4 mm arthroscopein addition to the world’s first 4.8 mm version previously released.Both products are available in eye-coupler and C-Mount options, which improves resolution and clarity overall. The use of 4.8 mm 4K arthroscopes, with the Synergy UHD4 4K imaging platform, produces a 59% increase in optical performance compared to the 4 mm HD scope with a 1080p system.

The United Nations (UN) and World Health Organization (WHO) recognized that the musculoskeletal conditions such as osteoarthritis, which is characterized by loss of joint cartilage that leads to pain and loss of function primarily in the knees and hips, affects 9.6% of men and 18% of women aged greater than 60 years. Rheumatoid arthritis is an inflammatory condition that usually affects multiple joints.It affects 0.3 - 1.0% of the U.S population and is more prevalent among women. Arthritis is the leading cause of disability, and causes pain, aching, stiffness, and swelling of the joints. Increasing life expectancy and ageing populations are expected to make osteoarthritis the fourth leading cause of disability by the year 2020.

Key Market Takeaways:

• The U.S. Arthroscopy devices market is expected to exhibit a CAGR of 6.1% during the forecast period (2019 – 2023),lesser time for surgery, technological advances in device accessories such as arthroscopic sheath systems, bridges, competitive bridges, and sheaths, cameras, and cannulas make arthroscopy easier, more effective and efficient. The growth in number of sport injuries where arthroscopy procedure avoids the total joint replacements is expect to induce the market growth.

• A few key competitors operating in the U.S. Arthroscopy Device market includes Arthrocare Corp., CorTek Endoscopy Inc., ConMed, Acumed, Aesculap, Arthrex, Inc., Aesculap, Stryker Corporation, Covidien Plc, Cannuflow, Olympus Corp., Synthes, Tornier Inc., DePuy Inc., Smith & Nephew Plc and Surgical innovations.

Optima Insights has a geographical/regional coverage on five major regions, include, North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. This extensive regional coverage also deep dives into major 26 countries, include, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.

For more details please log on to: www.optimainsights.org

About Optima Insights:

Optima Insights is an innovative research and insights driven enterprise committed to offer actionable intelligence to the global life science and healthcare market players. We believe that meaningful insights and improved strategic content holds the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas to develop targeted research solutions at compelling price point. We continuously support clients through the entire journey map to enable them take better business decisions towards attaining market leadership.

Contact Details:
Chucks G
Director - Global Sales & BD
Optima Insights Pvt. Ltd.,
mail: sales@optimainsights.org
mob: +1 4242554365
www.optimainsights.org

This release was published on openPR.